患有谷氨酸酸类型1的婴儿体内血瘤:保守管理的病例报告
Lúcia Marques1, Patrícia Lipari Pinto2, Hugo Loureiro Cadilha3
1Pediatrics Department. Hospital Beatriz Ângelo. Loures. Portugal.
Acta medica portuguesa
|August 7, 2025
概括
谷氨酸酸尿症1型可以引起皮下血液瘤. 婴儿中这些血液瘤的保守管理是有效的,并避免了代谢失补偿.
科学领域:
- 神经学 神经学
- 代谢障碍 代谢障碍 代谢障碍
- 儿科 儿科 儿科
背景情况:
- 谷氨酸酸尿症1型 (GA1) 是一种遗传性代谢障碍.
- GA1与皮下血瘤有关,可能是由于脑脊液空间扩大.
- 在患有GA1.1的婴儿中,巨头症和脑部增长加速可能会发生.
研究的目的:
- 为了呈现一个患有GA1的大型体内血瘤的婴儿病例.
- 为了评估GA1.1.中亚皮质血瘤的保守管理的有效性.
- 强调避免代谢失补偿的重要性.
主要方法:
- 新生儿查在患有先天性大脑的婴儿中诊断出GA1.
- 八个月的头骨MRI显示了双边的腹腔内血瘤与质量效应.
- 选择了保守的管理与密切监测,而不是手术干预.
主要成果:
- 婴儿在临床上保持稳定,没有创伤或虐待的迹象.
- 图像检测显示,体内皮层血瘤尺寸显著减少.
- 保守的管理证明在解决血瘤方面是有效的.
结论:
- 保守的管理可以是一个安全和有效的策略,在GA1.1.大质量效应的大型皮质血瘤.
- 这种方法可以避免与手术干预和潜在的代谢不补偿相关的风险.
- 在这些情况下,严密监测对于成功的保守管理至关重要.
相关概念视频
Glucose Transporters
Glucose transporters facilitate the transport of glucose across the cell membrane. In addition to glucose, some glucose transporters can also aid the movement of other hexoses such as fructose, mannose, and galactose.
Facilitated diffusion-glucose transporters (GLUTs) are encoded by the solute-linked carrier (SLC) family 2, subfamily A gene family, or SLC2A. The 14 GLUT protein members are distributed into three classes:
Facilitated diffusion-glucose transporters (GLUTs) are encoded by the solute-linked carrier (SLC) family 2, subfamily A gene family, or SLC2A. The 14 GLUT protein members are distributed into three classes:
Inborn Errors of Metabolism
Phenylketonuria (PKU) is a protein metabolism disorder characterized by high blood levels of the amino acid phenylalanine. This results from a mutation in the gene responsible for phenylalanine hydroxylase, an enzyme that converts phenylalanine into tyrosine. When this enzyme is deficient, phenylalanine builds up in the blood, leading to symptoms such as vomiting, rashes, seizures, growth deficiency, and severe mental retardation. An early diagnosis and a diet restricting phenylalanine intake...
Brain Abscess l: Introduction
A brain abscess is a focal, intracerebral infection characterized by a localized collection of pus within the brain parenchyma, resulting from microbial invasion and the body’s inflammatory response. It progresses through stages: early and late cerebritis, followed by early and late capsule formation, reflecting tissue destruction, immune response, and eventual encapsulation.Etiology and PathogenesisCausative organisms vary with source and host factors, often involving polymicrobial infections,...


